October 25, 2013
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 11, 2013, inter alia, to consider approval of unaudited financi...
October 7, 2013
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that "it has come to our knowledge that in the major pockets of the country our products are not being purchased by the trade from September 15,...
August 10, 2013
With new curbs on pricing, compulsory licences for cheaper versions of drugs and hyperactive US regulator, life is no longer easy for pharma companies. »
August 4, 2013
One MNC contests another’s patent on Tykerb. That’s fair game, if it finally benefits the patient.
London, July 24
GlaxoSmithKline (GSK) expects its financial performance in China to take a hit from Bejing’s probe into bribery allegedly carried out by senior staff, the British pharmaceuticals company said toda...
May 13, 2013
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that the 88th Annual General Meeting (AGM) of the Company was held on April 16, 2013.
Source : BSE - »
Coimbatore, May 7
Shares of MNC pharma major GlaxoSmithKline Pharmaceuticals Ltd were trading at a 52-week high despite posting a flat growth in Q1 of 2013 compared to the same quarter in the previous year. (The co...
May 7, 2013
GlaxoSmithKline Pharmaceuticals Ltd has announced the following Unaudited results for the quarter ended March 31, 2013:
The Company has posted a net profit of Rs. 1690.10 million for the q...
Coimbatore, April 30
Call it the Lever effect. After the promoters of MNC FMCG giant Hindustan Unilever Ltd surprised the market with a voluntary offer for sale announcement to mop up shares from the public, several M...
New Delhi, Oct 7
Drug maker GlaxoSmithKline Pharmaceuticals on Monday said its sales continue to be affected in the major pockets of the country as it products are not being purchased by stockists and retailers fr...
London, Oct 1
British drugs firm GlaxoSmithKline (GSK) today said that it has sold two thrombosis brands and a French plant to South African peer Aspen for $1.13 billion. “GSK today announced it has r...
Mumbai, Aug 8
An increased number of medicines under price control will affect drug-maker GlaxoSmithKline Pharmaceuticals’ annual revenues by about five percent, the company said. About 30 per c...
Mumbai, Aug 2
A special court on intellectual property in India has revoked a patent granted to drug-maker GlaxoSmithKline for breast cancer drug Tykerb.
In line with earlier judgments that disallowed...
Washington, June 6
Experts are re-examining a clinical trial of the GlaxoSmithKline diabetes drug Avandia, restricted in the US and banned in Europe amid concerns it raises heart attack risk, regulators said on Wedn...
Mumbai, May 7
Drug-maker GlaxoSmithKline Pharmaceuticals said that its growth of the core pharmaceuticals business suffered on account of supply chain constraints in parts of its Nashik facility as well as some...
May 4, 2013
Glaxo’s efforts to step up growth are yet to pay off, thanks to aggressive promotion by peers. »